Assessment and management of cutaneous reactions with amifostine administration: Findings of the ethyol (Amifostine) cutaneous treatment advisory panel (ECTAP)BOCCIA, Ralph; ANNE, Pramila Rani; WASSERMAN, Todd et al.International journal of radiation oncology, biology, physics. 2004, Vol 60, Num 1, pp 302-309, issn 0360-3016, 8 p.Article

Possible cefotaxime-induced Stevens-Johnson syndromeLIBEROPOULOS, Evagelos N; LIAMIS, George L; ELISAF, Moses S et al.The Annals of pharmacotherapy. 2003, Vol 37, Num 6, pp 812-814, issn 1060-0280, 3 p.Article

AQUACEL® Ag in the treatment of toxic epidermal necrolysis (TEN)HUANG, Shu-Hung; WU, Sheng-Hua; SUN, I-Feng et al.Burns. 2008, Vol 34, Num 1, pp 63-66, issn 0305-4179, 4 p.Article

Aquacel^® Ag with Vaseline gauze in the management of toxic epidermal necrolysis (TEN)HUANG, Shu-Hung; YANG, Pei-Shan; WU, Sheng-Hua et al.Burns. 2010, Vol 36, Num 1, pp 121-126, issn 0305-4179, 6 p.Article

Toxic epidermal necrolysis : Use of Biobrane® for skin coverage reduces pain, improves mobilisation and decreases infection in elderly patientsBOORBOOR, P; VOGT, P. M; BECHARA, F. G et al.Burns. 2008, Vol 34, Num 4, pp 487-492, issn 0305-4179, 6 p.Article

Intravenous immunoglobulin for treatment of toxic epidermal necrolysisNASSER, Maher; BITTERMAN-DEUTSCH, Ora; NASSAR, Faris et al.The American journal of the medical sciences. 2005, Vol 329, Num 2, pp 95-98, issn 0002-9629, 4 p.Article

Notfälle in der Allergologie : Notfälle in der Dermatologie = Emergencies in allergology : Emergencies in dermatologyBAUER, C; RUÄFF, F; PRZYBILLA, B et al.Hautarzt. 2004, Vol 55, Num 6, pp 525-532, issn 0017-8470, 8 p.Article

SCORTEN : Does it need modification?VAISHAMPAYAN, S. S; DAS, A. L; VERMA, R et al.Indian Journal of Dermatology Venereology and Leprology. 2008, Vol 74, Num 1, pp 35-37, issn 0378-6323, 3 p.Article

Dermatological and ophthalmological sequels in Toxic epidermal necrolysisMAGINA, S; LISBOA, C; LEAL, V et al.Dermatology (Basel). 2003, Vol 207, Num 1, pp 33-36, issn 1018-8665, 4 p.Article

Outcome of patients with toxic epidermal necrolysis syndrome revisitedDUCIC, Ivica; SHALOM, Avshalom; RISING, William et al.Plastic and reconstructive surgery (1963). 2002, Vol 110, Num 3, pp 768-773, issn 0032-1052Article

Radiotherapy: a protective role for toxic epidermal necrolysis?HAFIJI, J; ORPIN, S; ROBERTS, C et al.British journal of dermatology (1951). 2010, Vol 162, Num 5, pp 1139-1141, issn 0007-0963, 3 p.Article

Sera from patients with toxic epidermal necrolysis contain autoantibodies to periplakinPARK, G. T; QUAN, G; LEE, J. B et al.British journal of dermatology (1951). 2006, Vol 155, Num 2, pp 337-343, issn 0007-0963, 7 p.Article

Skin manifestations of drug allergy : Drug allergyARDERN-JONES, Michael R; FRIEDMANN, Peter S.British journal of clinical pharmacology. 2011, Vol 71, Num 5, pp 672-683, issn 0306-5251, 12 p.Article

High-dose intravenous immunoglobulin in the treatment of toxic epidermal necrolysis : a study of ocular benefitsYIP, L. W; THONG, B. Y; TAN, A. W et al.Eye (London. 1987). 2005, Vol 19, Num 8, pp 846-853, issn 0950-222X, 8 p.Article

Roxithromycin-Induced Toxic Epidermal NecrolysisDAS, Saibal; MONDAL, Somnath; KUMAR DEY, Jayanta et al.Therapeutic drug monitoring. 2012, Vol 34, Num 4, pp 359-362, issn 0163-4356, 4 p.Article

Caspofungin-Induced Severe Toxic Epidermal NecrolysisLEE, Ming-Chia; NI, Ya-Wen; WANG, Chun-Hua et al.The Annals of pharmacotherapy. 2010, Vol 44, Num 6, pp 1116-1118, issn 1060-0280, 3 p.Article

Toxic epidermal necrolysis as a dermatological manifestation of drug hypersensitivity syndromePETKOV, Todor; PEHLIVANOV, Georgy; GROZDEV, Ivan et al.EJD. European journal of dermatology. 2007, Vol 17, Num 5, pp 422-427, issn 1167-1122, 6 p.Article

Uso de inmunoglobulina intravenosa en el tratamiento de necrólisis epidérmica tóxica y síndrome de stevens-johnson = Use of intravenous immunoglobulin in toxic epidermal necrolysis and stevens-johnson syndromeKÜHN-CORDOVA, I; RAMIREZ-BOUCHAN, D; GAMBOA-MARRUFO, J. D et al.Anales de pediatria (2003. Ed. impresa). 2007, Vol 67, Num 1, pp 68-73, issn 1695-4033, 6 p.Article

Toxic epidermal necrolysis-like reaction secondary to colchicine overdoseARROYO, M. P; SANDERS, S; YEE, H et al.British journal of dermatology (1951). 2004, Vol 150, Num 3, pp 581-588, issn 0007-0963, 8 p.Article

High-dose intravenous immunoglobulin for severe drug reactions: Efficacy in toxic epidermal necrolysisCAMPIONE, Elena; MARULLI, Georgiana Clare; CARROZZO, Anna Maria et al.Acta dermato-venereologica. 2003, Vol 83, Num 6, pp 430-432, issn 0001-5555, 3 p.Article

Profile and Pattern of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in a General Hospital in Singapore: Treatment OutcomesTAN, Siew-Kiang; TAY, Yong-Kwang.Acta dermato-venereologica. 2012, Vol 92, Num 1, pp 62-66, issn 0001-5555, 5 p.Article

Granulocyte colony-stimulating factor in toxic epidermal necrolysis (TEN) and Chelsea & Westminster TEN protocolDE SICA-CHAPMAN, A; WILLIAMS, G; SONI, N et al.British journal of dermatology (1951). 2010, Vol 162, Num 4, pp 860-865, issn 0007-0963, 6 p.Article

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: What Do We Know?TARTARONE, Alfredo; LEROSE, Rosa.Therapeutic drug monitoring. 2010, Vol 32, Num 6, pp 669-672, issn 0163-4356, 4 p.Article

Cystic lesion of the parotid following drug-induced toxic epidermal necrolysis (Lyell's syndrome)PAQUET, P; JACOB, E; PIERARD, G. E et al.Journal of oral pathology & medicine. 2005, Vol 34, Num 6, pp 380-382, issn 0904-2512, 3 p.Article

Toxic epidermal necrolysis and Stevens-Johnson syndromeHUSSAIN, Walayat; CRAVEN, Nicholas M.Clinical medicine. 2005, Vol 5, Num 6, pp 555-558, issn 1470-2118, 4 p.Article